Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultraviolet Rays | 18 | 2015 | 193 | 2.620 |
Why?
|
| Skin Neoplasms | 15 | 2015 | 546 | 1.960 |
Why?
|
| Keratinocytes | 13 | 2014 | 143 | 1.770 |
Why?
|
| DNA Repair | 9 | 2015 | 356 | 1.420 |
Why?
|
| PTEN Phosphohydrolase | 6 | 2012 | 128 | 1.110 |
Why?
|
| Carcinoma, Squamous Cell | 9 | 2015 | 1076 | 0.950 |
Why?
|
| Proto-Oncogene Proteins c-akt | 10 | 2015 | 322 | 0.890 |
Why?
|
| DNA Damage | 7 | 2015 | 366 | 0.770 |
Why?
|
| Skin | 6 | 2015 | 554 | 0.670 |
Why?
|
| Carcinogenesis | 5 | 2015 | 195 | 0.610 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 1135 | 0.580 |
Why?
|
| Twist-Related Protein 1 | 3 | 2015 | 13 | 0.570 |
Why?
|
| Nuclear Proteins | 4 | 2015 | 696 | 0.560 |
Why?
|
| Autophagy | 3 | 2015 | 149 | 0.510 |
Why?
|
| Apoptosis | 8 | 2015 | 1683 | 0.450 |
Why?
|
| Immunosuppressive Agents | 3 | 2014 | 977 | 0.440 |
Why?
|
| Sirtuin 1 | 2 | 2014 | 32 | 0.440 |
Why?
|
| Neoplasms, Radiation-Induced | 3 | 2011 | 109 | 0.430 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2015 | 427 | 0.420 |
Why?
|
| Saccharomyces | 1 | 2012 | 21 | 0.420 |
Why?
|
| DNA-Binding Proteins | 6 | 2015 | 1208 | 0.410 |
Why?
|
| Pan troglodytes | 1 | 2013 | 197 | 0.410 |
Why?
|
| Proteomics | 2 | 2018 | 212 | 0.400 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 378 | 0.400 |
Why?
|
| Macaca mulatta | 1 | 2013 | 459 | 0.390 |
Why?
|
| Fungal Proteins | 1 | 2012 | 141 | 0.390 |
Why?
|
| Mice | 18 | 2015 | 11352 | 0.380 |
Why?
|
| Fluoroquinolones | 1 | 2010 | 22 | 0.370 |
Why?
|
| Cyclosporine | 2 | 2012 | 234 | 0.370 |
Why?
|
| Fluorescence | 1 | 2010 | 102 | 0.370 |
Why?
|
| Cell Survival | 5 | 2014 | 969 | 0.370 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 1920 | 0.360 |
Why?
|
| Photochemotherapy | 2 | 2010 | 97 | 0.350 |
Why?
|
| Selection, Genetic | 1 | 2013 | 502 | 0.350 |
Why?
|
| Photosensitizing Agents | 2 | 2009 | 48 | 0.350 |
Why?
|
| Animals | 22 | 2015 | 26582 | 0.330 |
Why?
|
| Alleles | 1 | 2012 | 1128 | 0.320 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2014 | 302 | 0.320 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1981 | 0.310 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 813 | 0.310 |
Why?
|
| Cyclooxygenase 2 | 2 | 2014 | 100 | 0.300 |
Why?
|
| Down-Regulation | 6 | 2015 | 504 | 0.290 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 125 | 0.260 |
Why?
|
| Cockayne Syndrome | 1 | 2015 | 4 | 0.260 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2015 | 9 | 0.260 |
Why?
|
| Trichothiodystrophy Syndromes | 1 | 2015 | 4 | 0.260 |
Why?
|
| Keratosis, Actinic | 2 | 2011 | 11 | 0.250 |
Why?
|
| Focal Adhesions | 1 | 2015 | 69 | 0.250 |
Why?
|
| Sirtuins | 1 | 2014 | 45 | 0.250 |
Why?
|
| Keratin-19 | 1 | 2014 | 9 | 0.250 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 70 | 0.250 |
Why?
|
| Sirtuin 2 | 1 | 2014 | 9 | 0.240 |
Why?
|
| Mycophenolic Acid | 1 | 2014 | 87 | 0.240 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 103 | 0.240 |
Why?
|
| Cells, Cultured | 6 | 2015 | 2818 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 1197 | 0.240 |
Why?
|
| Allergens | 1 | 2014 | 179 | 0.230 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 302 | 0.230 |
Why?
|
| Caffeine | 2 | 2011 | 81 | 0.230 |
Why?
|
| Skin Diseases | 1 | 2015 | 166 | 0.230 |
Why?
|
| Humans | 29 | 2018 | 86643 | 0.230 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 179 | 0.230 |
Why?
|
| Tacrolimus | 1 | 2014 | 373 | 0.220 |
Why?
|
| Wound Healing | 1 | 2015 | 344 | 0.220 |
Why?
|
| Cyclophilin A | 1 | 2012 | 4 | 0.220 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2012 | 6 | 0.220 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 115 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2014 | 1924 | 0.210 |
Why?
|
| Glutathione | 1 | 2012 | 104 | 0.210 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 214 | 0.200 |
Why?
|
| HeLa Cells | 4 | 2014 | 498 | 0.200 |
Why?
|
| Keratosis, Seborrheic | 1 | 2011 | 6 | 0.200 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2011 | 5 | 0.200 |
Why?
|
| Species Specificity | 2 | 2013 | 678 | 0.190 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 532 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 74 | 0.190 |
Why?
|
| Aging | 1 | 2015 | 691 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 246 | 0.180 |
Why?
|
| Homeostasis | 1 | 2012 | 409 | 0.180 |
Why?
|
| Organosilicon Compounds | 1 | 2009 | 4 | 0.180 |
Why?
|
| Epidermis | 3 | 2014 | 100 | 0.180 |
Why?
|
| Fullerenes | 1 | 2009 | 2 | 0.180 |
Why?
|
| gamma-Cyclodextrins | 1 | 2009 | 3 | 0.180 |
Why?
|
| Metalloproteases | 1 | 2009 | 10 | 0.170 |
Why?
|
| S Phase | 1 | 2009 | 62 | 0.170 |
Why?
|
| G1 Phase | 1 | 2009 | 63 | 0.170 |
Why?
|
| Phosphopeptides | 1 | 2018 | 11 | 0.170 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 8 | 0.170 |
Why?
|
| Organ Transplantation | 1 | 2012 | 265 | 0.170 |
Why?
|
| Cell Proliferation | 4 | 2015 | 1578 | 0.160 |
Why?
|
| Lens, Crystalline | 1 | 2009 | 69 | 0.160 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 216 | 0.160 |
Why?
|
| Melanoma | 2 | 2009 | 459 | 0.160 |
Why?
|
| Checkpoint Kinase 1 | 3 | 2012 | 13 | 0.160 |
Why?
|
| Indoles | 1 | 2009 | 318 | 0.150 |
Why?
|
| Proteome | 1 | 2018 | 124 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2018 | 254 | 0.150 |
Why?
|
| Cell Line | 4 | 2014 | 2468 | 0.150 |
Why?
|
| Up-Regulation | 3 | 2014 | 712 | 0.140 |
Why?
|
| Mice, Nude | 3 | 2014 | 790 | 0.140 |
Why?
|
| Protein Kinases | 3 | 2012 | 209 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 371 | 0.140 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 547 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2012 | 692 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2009 | 669 | 0.130 |
Why?
|
| Protein Stability | 2 | 2014 | 99 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2012 | 1565 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2018 | 1106 | 0.120 |
Why?
|
| Sequestosome-1 Protein | 2 | 2014 | 22 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2015 | 3241 | 0.120 |
Why?
|
| Tumor Burden | 2 | 2014 | 289 | 0.110 |
Why?
|
| Lysosomes | 2 | 2014 | 104 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2015 | 615 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 3092 | 0.110 |
Why?
|
| Neoplasms | 2 | 2014 | 2898 | 0.100 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2012 | 52 | 0.100 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2012 | 61 | 0.100 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 104 | 0.100 |
Why?
|
| Genes, p53 | 2 | 2012 | 109 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 188 | 0.100 |
Why?
|
| Photochemistry | 1 | 2010 | 38 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2012 | 596 | 0.090 |
Why?
|
| Singlet Oxygen | 2 | 2009 | 7 | 0.090 |
Why?
|
| Precancerous Conditions | 2 | 2011 | 196 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2010 | 287 | 0.090 |
Why?
|
| RNA Interference | 2 | 2010 | 369 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 2426 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 493 | 0.090 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 276 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 388 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 279 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2012 | 729 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1753 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 434 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 2232 | 0.080 |
Why?
|
| Models, Biological | 2 | 2015 | 1749 | 0.080 |
Why?
|
| Pyrimidine Dimers | 1 | 2015 | 4 | 0.070 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2015 | 11 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1384 | 0.070 |
Why?
|
| Mice, Inbred SENCAR | 1 | 2015 | 4 | 0.070 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2014 | 15 | 0.060 |
Why?
|
| Adenylate Kinase | 1 | 2014 | 13 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2014 | 35 | 0.060 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 55 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2014 | 88 | 0.060 |
Why?
|
| DNA Repair Enzymes | 1 | 2015 | 52 | 0.060 |
Why?
|
| Mast Cells | 1 | 2014 | 92 | 0.060 |
Why?
|
| Random Allocation | 1 | 2015 | 332 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 235 | 0.060 |
Why?
|
| Oncogenes | 1 | 2014 | 88 | 0.060 |
Why?
|
| Keratin-15 | 1 | 2014 | 3 | 0.060 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 144 | 0.060 |
Why?
|
| RNA Stability | 1 | 2014 | 86 | 0.060 |
Why?
|
| Dermatitis, Atopic | 1 | 2014 | 52 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 100 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2014 | 137 | 0.060 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 391 | 0.060 |
Why?
|
| Reference Values | 1 | 2015 | 674 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2014 | 158 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2014 | 329 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 192 | 0.050 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2011 | 23 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2012 | 64 | 0.050 |
Why?
|
| Papilloma | 1 | 2011 | 22 | 0.050 |
Why?
|
| Chromones | 1 | 2011 | 28 | 0.050 |
Why?
|
| Mice, Hairless | 1 | 2011 | 5 | 0.050 |
Why?
|
| Time Factors | 1 | 2010 | 5210 | 0.050 |
Why?
|
| Morpholines | 1 | 2011 | 65 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 37 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 30 | 0.050 |
Why?
|
| Histones | 1 | 2012 | 311 | 0.050 |
Why?
|
| Cell Movement | 1 | 2014 | 758 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 63 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 207 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 262 | 0.050 |
Why?
|
| Gene Expression | 1 | 2014 | 1284 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 1056 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 134 | 0.040 |
Why?
|
| Peroxidases | 1 | 2009 | 34 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 2009 | 39 | 0.040 |
Why?
|
| Particle Size | 1 | 2009 | 122 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2012 | 444 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2010 | 782 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2011 | 502 | 0.040 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2009 | 54 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2009 | 81 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 879 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2010 | 579 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 71 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 381 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 639 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 103 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2009 | 157 | 0.040 |
Why?
|
| Temperature | 1 | 2009 | 396 | 0.040 |
Why?
|
| Genome | 1 | 2010 | 372 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2009 | 679 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 315 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1196 | 0.040 |
Why?
|
| Female | 3 | 2014 | 44532 | 0.040 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2009 | 306 | 0.040 |
Why?
|
| Male | 3 | 2015 | 40965 | 0.040 |
Why?
|
| Base Sequence | 1 | 2010 | 2330 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 1851 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 2360 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2357 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 3968 | 0.020 |
Why?
|